Atlas Trials

Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder

Clinical trial NCT02662309 · COMPLETED

Trial details

NCT number
NCT02662309
Sponsor
Queen Mary University of London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2016-02-01
Primary completion
2020-06-11
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.